+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autoimmune Disease Diagnosis - Global Market Trajectory & Analytics

  • ID: 4804456
  • Report
  • April 2021
  • Region: Global
  • 282 pages
  • Global Industry Analysts, Inc
Global Autoimmune Disease Diagnosis Market to Reach $6 Billion by 2027

Amid the COVID-19 crisis, the global market for Autoimmune Disease Diagnosis estimated at US$3.6 Billion in the year 2020, is projected to reach a revised size of US$6 Billion by 2027, growing at a CAGR of 7.6% over the analysis period 2020-2027. Consumables & Assay Kits, one of the segments analyzed in the report, is projected to record a 8.1% CAGR and reach US$3.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.3% CAGR for the next 7-year period.



The U.S. Market is Estimated at $959.8 Million, While China is Forecast to Grow at 11.6% CAGR

The Autoimmune Disease Diagnosis market in the U.S. is estimated at US$959.8 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2027 trailing a CAGR of 11.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 6.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Services Segment to Record 6.6% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 6.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$423.1 Million in the year 2020 will reach a projected size of US$641.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$819.7 Million by the year 2027, while Latin America will expand at a 7.9% CAGR through the analysis period.

Select Competitors (Total 42 Featured):
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Euroimmun AG
  • Grifols International SA
  • Hycor Biomedical, Inc.
  • INOVA Diagnostics, Inc.
  • Protagen AG
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Autoimmune Disease Diagnosis Market: Prelude
  • Exhibit 1: Global Autoimmune Disease Diagnosis Market: Percentage Breakdown of Revenues by End-Use Segment for 2019
  • Exhibit 2: Global Systemic Autoimmune Disease Diagnostics Market: Percentage Breakdown of Revenues by Type for 2019
  • Impact of Covid-19 and a Looming Global Recession
  • Rising Incidence and Huge Economic Burden of Autoimmune Disorders Drives Focus onto Autoimmune Disease Diagnosis
  • Statistics on Select Autoimmune Diseases
  • Rheumatoid Arthritis
  • Exhibit 3: Global Rheumatoid Arthritis Prevalence: Number of Prevalent RA Cases among Adults in Select Countries for the Years 2015 and 2025
  • Exhibit 4: Arthritis in the US: Number of Adults with Doctor-Diagnosed Arthritis for the Years 2015, 2020, 2025, 2030, 2035, 2040
  • Systemic Lupus Erythematosus
  • Thyroiditis
  • Scleroderma
  • Increase in Healthcare Spending Worldwide Augurs Well for Autoimmune Diagnosis Market
  • Exhibit 5: Global Healthcare Outlook: Spending in US$ Billion for 2017 and 2022
  • Exhibit 6: Global Healthcare Spending: Top Countries Ranked by Public Health Spending Per Capital (in $) and Share of GDP Spent on Public Health
  • Evolving Autoimmune Diagnostics Space, Automation of Autoimmunology Lab and Reduced Turnaround Times: Changes with Positive Implications for the Market
  • Antinuclear Autoantibodies (ANA) Blood Test: Enabling Diagnosis of Autoimmune Diseases
  • Developments in ANA Testing Facilitate Detection of Systemic Autoimmune Rheumatic Diseases
  • Lab Testing for Autoimmune Diseases: Continuous Developments Aid in Improving Diagnosis Capabilities
  • Multiplex Flow Immunoassay Emerges as a High Performance Technique for ANA Screening for Autoimmune Diseases
  • RNA Testing for Diagnosis of Autoimmune Disease: A Faster and Accurate Method
  • AVISE® CTD: New Blood Test for Lupus Diagnosis
  • PRODUCT OVERVIEW
  • Autoimmune Diseases
  • Diagnosis of Autoimmune Diseases
III. MARKET ANALYSIS
  • Autoimmune Disease Diagnostics Market in the US: An Overview
  • Exhibit 7: Autoimmune Disease Diagnostics Market in the US: Percentage Breakdown of Revenues by Product for 2019 and 2025
  • An Insight into Autoimmune Disease Diagnostics Market in Europe
  • Exhibit 8: European Autoimmune Disease Diagnostics Market: Percentage Breakdown of Revenues by Systemic Autoimmune Disease for 2019
  • Exhibit 9: Autoimmune Disease Diagnostics Market in Germany: Percentage Breakdown of Revenues by Product for 2019
  • Asia-Pacific Autoimmune Disease Diagnostics Market: A High Growth Market
IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown
Adroll
adroll